PNEUMOCOCCAL VACCINATION WITH 13-VALENT POLYSACCHARIDE CONJUGATE VACCINE FOR OLDER ADULTS WITH CHRONIC CONDITIONS: BUDGET IMPACT ANALYSIS IN COLOMBIA

被引：0

作者：

LaRotta, J. ^{[1
]}

Sanchez, Reyes J. M. ^{[2
]}

Gamboa, Castano N. ^{[1
]}

机构：

[1] Pfizer SAS, Bogota, Colombia

[2] Pfizer SAS, Bogota, Cun, Colombia

来源：

VALUE IN HEALTH | 2022年 / 25卷 / 01期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

POSC103

引用

页码：S107 / S107

页数：1

共 50 条

[1] Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed): In older adults
Sanford M.
Drugs, 2012, 72 (9) : 1243 - 1255
[2] Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) In Older Adults
Sanford, Mark
DRUGS, 2012, 72 (09) : 1243 - 1255
[3] Erratum to Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed): In Older Adults
M. Sanford
Drugs, 2012, 72 : 2176 - 2176
[4] Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Jaime E Ordóñez
John J Orozco
BMC Infectious Diseases, 14
[5] Cost-effectiveness analysis of pneumococcal conjugate vaccine 13-valent in older adults in Colombia
Ordonez, Jaime E.
Orozco, John J.
BMC INFECTIOUS DISEASES, 2014, 14
[6] Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed)A Guide to Its Use in Older Adults
Lesley J. Scott
Mark Sanford
Drugs & Aging, 2012, 29 : 847 - 855
[7] Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) A Guide to Its Use in Older Adults
Scott, Lesley J.
Sanford, Mark
DRUGS & AGING, 2012, 29 (10) : 847 - 855
[8] A public health and budget impact analysis of vaccinating the elderly and at-risk adults with the 23-valent pneumococcal polysaccharide vaccine or 13-valent pneumococcal conjugate vaccine in the UK
Jiang, Yiling
Gauthier, Aline
Keeping, Sam
Carroll, Stuart
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2014, 14 (06) : 901 - 911
[9] Pneumococcal vaccination strategies in adult population: perspectives with the pneumococcal 13-Valent polysaccharide conjugate vaccine
Alicino, C.
Barberis, I.
Orsi, A.
Durando, P.
MINERVA MEDICA, 2014, 105 (01) : 89 - 97
[10] Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus "no vaccination" and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine
Gouveia, Miguel
Jesus, Goncalo
Ines, Monica
Costa, Joao
Borges, Margarida
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (04) : 850 - 858

← 1 2 3 4 5 →